The prediction of immunological dysfunction during antiviral therapy for HCV after liver transplantation: can we improve outcomes?
Hepatol Int
.
2013 Oct;7(4):948-50.
doi: 10.1007/s12072-013-9474-8.
Epub 2013 Oct 17.
Authors
Ji-Yuan Zhang
1
,
Yuan-Yuan Li
1
,
Zheng Zhang
1
,
Fu-Sheng Wang
2
Affiliations
1
Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, 100039, China.
2
Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, 100039, China.
[email protected]
.
PMID:
26202024
DOI:
10.1007/s12072-013-9474-8
No abstract available